Medications
Substandard, non-approved drugs put patients at risk
and the subsequent deaths of 15 individuals—has renewed scrutiny on the contemporary practice of pharmacy compounding. The risks to patients, and associated liability risk to prescribing physicians, largely outweigh the ...
Oct 15, 2012
0
0
